---
title: "Hengrui Pharma launches RMB 1 billion-RMB 2 billion A-share buyback, caps price at RMB 81.78"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296368941.md"
description: "Jiangsu Hengrui Medicine Co. Ltd. launched an A-share buyback plan ranging from RMB 1 billion to RMB 2 billion via centralized price bidding. The repurchased shares will fund an employee stock ownership scheme, with a maximum purchase price capped at RMB 81.78 per share. The program is scheduled to run for up to 12 months starting August 19, 2026, targeting the acquisition of approximately 12.2 million to 24.5 million shares."
datetime: "2026-08-19T14:15:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296368941.md)
  - [en](https://longbridge.com/en/news/296368941.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296368941.md)
---

# Hengrui Pharma launches RMB 1 billion-RMB 2 billion A-share buyback, caps price at RMB 81.78

-   Jiangsu Hengrui launched an A-share buyback plan of RMB 1-2 billion via centralized price bidding. \* Repurchases to fund an A-share employee stock ownership scheme; maximum price set at RMB 81.78 per share. \* Program runs up to 12 months from Aug. 19, 2026; estimated 12,227,900-24,455,900 shares, or 0.18%-0.37% of share capital. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Hengrui Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12291176), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)
- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Hengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A Shares](https://longbridge.com/en/news/296370263.md)
- [Jiangsu Hengrui files HKEX next-day disclosure return after share repurchase for treasury shares](https://longbridge.com/en/news/295383271.md)
- [2 GLP-1 Stocks That Could Double Your Money by 2031](https://longbridge.com/en/news/296030914.md)
- [China Castson 81 Finance schedules board meeting to review interim results](https://longbridge.com/en/news/296076831.md)
- [Reploid plans 1-for-15 stock split to boost share tradability](https://longbridge.com/en/news/296072959.md)